Latest filing published 20 Oct 2020 for Aligos Therapeutics, Inc..
Insider track record
No signal scores available.
Julian A. Symons: trading record in brief
All filings by Julian A. Symons on record concern Aligos Therapeutics, Inc. In total, 3 filings cover trades dated 20 October 2020.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 20 October 2020, the filings show a transaction in Aligos Therapeutics, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julian A. Symons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,671 sharesCommon StockSEC:0001567619-20-018006:0
- 3,394 sharesCommon StockSEC:0001567619-20-018006:1
- 1,452 sharesCommon StockSEC:0001567619-20-018006:2
3 of 3 declarations
